An investigation of 84 breast-cancer associated genes in 18 TNBC (ER-/PR-/HER2-) and 12 Her2-overexpressing (ER-/PR-/HER2+) BC patients revealed 15 genes that were differentially expressed, even though HER2- and HER2+ groups had comparable counts of nucleated cells in blood [11]. This evidence concerns the gene ERBB2 and breast carcinoma.